F

Fundacao Universidade de Caxias do Sul | Instituto de Pesquisas em Saude

Research site
(Unclaimed)
Location
Francisco Getulio Vargas 1130, Caxias do Sul, Rio Grande do Sul, Brazil
Site insights

Top conditions

Plasma Cell Cancer (2 trials)

Multiple Myeloma (2 trials)

Lymphoma (1 trial)

Colitis (1 trial)

Ulcer (1 trial)

Top treatments

Pomalidomide
Dexamethasone
Bortezomib
Daratumumab
Carfilzomib
Teclistamab
Lenalidomide
Zanubrutinib
Guselkumab
PVd

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment (MonumenTAL-3)

The purpose of the study is to compare the efficacy of talquetamab subcutaneous(ly) (SC) in combination with daratumumab SC and pomalidomide (Tal-DP)...

Enrolling
Relapsed or Refractory Multiple Myeloma
Drug: Pomalidomide
Drug: Daratumumab

The purpose of this study is to compare the efficacy of teclistamab with PVd/Kd.

Enrolling
Relapsed or Refractory Multiple Myeloma
Drug: Dexamethasone
Drug: Teclistamab

The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderat...

Enrolling
Colitis, Ulcerative
Drug: Placebo
Biological: Golimumab

The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R^2) in participants with r...

Enrolling
Relapsed/Refractory Follicular Lymphoma
Marginal Zone Lymphoma
Drug: Rituximab
Drug: Zanubrutinib

Trial sponsors

Janssen logo

Janssen (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems